Moderna, Inc.
MRNA · NASDAQ
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 18.88B | 13.46B | 9.42B | 8.36B | 21.26 |
| 2023 FY | 6.85B | 2.16B | -4.24B | -4.71B | -12.34 |
| 2024 FY | 3.20B | 1.74B | -3.95B | -3.56B | -9.27 |
| 2025 FY | 1.94B | 1.08B | -3.07B | -2.82B | -7.26 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 25.86B | 6.74B | 3.21B | 1.20B | 19.12B |
| 2023 FY | 18.43B | 4.57B | 2.91B | 1.24B | 13.85B |
| 2024 FY | 14.14B | 3.24B | 1.93B | 747.00M | 10.90B |
| 2025 FY | 12.34B | 3.69B | 2.60B | 1.92B | 8.65B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 4.98B | -400.00M | 4.58B | — | -3.64B |
| 2023 FY | -3.12B | -707.00M | -3.83B | — | -289.00M |
| 2024 FY | -3.00B | -1.05B | -4.06B | — | -999.00M |
| 2025 FY | -1.87B | -192.00M | -2.07B | — | 668.00M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 70.77B | 68.77B | — | — | — |
| 2023 FY | 37.99B | 36.33B | — | — | — |
| 2024 FY | 15.97B | 14.79B | — | — | — |
| 2025 FY | 11.47B | 10.79B | — | — | — |
| 2026-12-31 | — | — | — | — | — |
| 2027-12-31 | — | — | — | — | — |
| 2028-12-31 | — | — | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 142.00M | 23.00M | -907.00M | -825.00M | -2.13 |
| 2025 Q3 | 1.02B | 8.00M | -260.00M | -200.00M | -0.51 |
| 2025 Q4 | 678.00M | 226.00M | -857.00M | -826.00M | -2.11 |
| 2026 Q1 | 389.00M | -566.00M | -1.39B | -1.34B | -3.40 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 12.01B | 2.61B | 1.28B | 741.00M | 9.40B |
| 2025 Q3 | 12.14B | 2.81B | 1.13B | 1.39B | 9.33B |
| 2025 Q4 | 12.34B | 3.69B | 2.60B | 1.92B | 8.65B |
| 2026 Q1 | 11.49B | 4.08B | 1.91B | 1.30B | 7.41B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | -919.00M | -3.00M | -922.00M | — | -345.00M |
| 2025 Q3 | -847.00M | -33.00M | -880.00M | — | -147.00M |
| 2025 Q4 | 951.00M | -39.00M | 912.00M | — | 1.46B |
| 2026 Q1 | -630.00M | -62.00M | -692.00M | — | -688.00M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 10.70B | 10.17B | — | — | — |
| 2025 Q3 | 10.07B | 10.34B | — | — | — |
| 2025 Q4 | 11.56B | 10.88B | — | — | — |
| 2026 Q1 | 20.07B | 19.46B | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2026-09-30 | — | — | — | — | — |
| 2026-12-31 | — | — | — | — | — |